EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study

Frederick K Ho iD, Caroline Dale, Mehrdad A Mizani iD, Thomas Bolton iD, Ewan R Pearson, Jonathan Valabhji, Christian Delles iD, Paul Welsh iD, Shinya Nakada, Daniel Mackay, Jill P Pell, Chris Tomlinson iD und 10 weitere

PLOS Medicine · 2024

DOI: 10.1371/journal.pmed.1004485 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS Medicine, 2024. Verfasst von Frederick K Ho und 21 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Primary Health Care, Cardiometabolic Risk Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study estimated to what extent the number of measurements of cardiometabolic risk factors (e.g., blood pressure, cholesterol, glycated haemoglobin) were impacted by the COVID-19 pandemic and whether these have recovered to expected levels. Methods and findings A cohort of individuals aged ≥18 years in England with records in the primary care—COVID-19 General Practice Extraction Service Data for Pandemic Planning and Research (GDPPR) were identified. Their records of 12 risk factor measurements were extracted between November 2018 and March 2024. Number of measurements per 1,000 individuals were calculated by age group, sex, ethnicity, and area deprivation quintile. The observed number of measurements were compared to a composite expectation band, derived as the union of the 95% confidence intervals of 2 estimates: (1) a projected trend based on data prior to the COVID-19 pandemic; and (2) an assumed stable trend from before pandemic. Point estimates were calculated as the mid-point of the expectation band. A cohort of 49,303,410 individuals aged ≥18 years were included. There was sharp drop in all measurements in March 2020 to February 2022, but overall recovered to the expected levels during March 2022 to February 2023 except for blood pressure, which had prolonged recovery. In March 2023 to March 2024, blood pressure measurements were below expectation by 16% (−19 per 1,000) overall, in people aged 18 to 39 (−23%; −18 per 1,000), 60 to 79 (−17%; −27 per 1,000), and ≥80 (−31%; −57 per 1,000). There was suggestion that recovery in blood pressure measurements was socioeconomically patterned. The second most deprived quintile had the highest deviation (−20%; −23 per 1,000) from expectation compared to least deprived quintile (−13%; −15 per 1,000).

Conclusions

There was a substantial reduction in routine measurements of cardiometabolic risk factors following the COVID-19 pandemic, with variable recovery. The implications for missed diagnoses, worse prognosis, and health inequality are a concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Primary Health CareCardiometabolic Risk FactorsHumansEnglandMaleFemaleAdultMiddle AgedAgedCohort StudiesAdolescentYoung AdultSARS-CoV-2PandemicsBlood PressureRisk FactorsGlycated HemoglobinCardiovascular DiseasesCholesterolAged, 80 and over

Substanzen

Glycated HemoglobinCholesterol

Autor:innen und Institutionen

  • School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
  • Department of Pharmacology & Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • British Heart Foundation Data Science Centre, Health Data Research UK, London, United Kingdom.
  • Division of Population Health & Genomics, University of Dundee, Dundee, United Kingdom.
  • Division of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.

ORCID-Profile: Frederick K Ho, Mehrdad A Mizani, Thomas Bolton, Christian Delles, Paul Welsh, Chris Tomlinson, Steffen E Petersen, Kazem Rahimi, Julian Halcox, Cathie Sudlow, Naveed Sattar

Förderung

  • British Heart Foundation

Zitieren

APA

Ho, F. K., Dale, C., Mizani, M. A., Bolton, T., Pearson, E. R., Valabhji, J., Delles, C., Welsh, P., Nakada, S., Mackay, D., Pell, J. P., Tomlinson, C., Petersen, S. E., Bray, B., Ashworth, M., Rahimi, K., Mamas, M., Halcox, J., Sudlow, C., …, & CVD-COVID-UK/COVID-IMPACT Consortium (2024). Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004485

Vancouver

Ho FK, Dale C, Mizani MA, Bolton T, Pearson ER, Valabhji J, et al. Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study. PLOS Medicine. 2024. doi:10.1371/journal.pmed.1004485

BibTeX
@article{Ho2024,
  author = {Ho, Frederick K and Dale, Caroline and Mizani, Mehrdad A and Bolton, Thomas and Pearson, Ewan R and Valabhji, Jonathan and Delles, Christian and Welsh, Paul and Nakada, Shinya and Mackay, Daniel and Pell, Jill P and Tomlinson, Chris and Petersen, Steffen E and Bray, Benjamin and Ashworth, Mark and Rahimi, Kazem and Mamas, Mamas and Halcox, Julian and Sudlow, Cathie and Sofat, Reecha and Sattar, Naveed and CVD-COVID-UK/COVID-IMPACT Consortium, CVD-COVID-UK/COVID-IMPACT Consortium},
  title = {Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study},
  journal = {PLOS Medicine},
  year = {2024},
  doi = {10.1371/journal.pmed.1004485}
}
Kostenlos starten →